Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges
Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges. // Artificial Intelligence in the Life Sciences. – URL: https://www.sciencedirect.com/science/article/pii/S2667318526000164?dgcid=rss_sd_all
Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges. Artificial Intelligence in the Life Sciences. https://www.sciencedirect.com/science/article/pii/S2667318526000164?dgcid=rss_sd_all
“Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges.” Artificial Intelligence in the Life Sciences.
@article{article36920,
title = {Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges},
journal = {Artificial Intelligence in the Life Sciences},
url = {https://www.sciencedirect.com/science/article/pii/S2667318526000164?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Artificial Intelligence in the Life Sciences, Volume 10 Author(s): Armin Ahmadi, Russell Bechmann, Vasista Baderdinni, Antonio Lampasi, Sivashankar Sivakollundu, Richard Paul, Tim Stevens
Publication date: December 2026 Source: Artificial Intelligence in the Life Sciences, Volume 10 Author(s): Emma Granqvist, Rocío Mercado, Samuel Genheden
Publication date: December 2026 Source: Artificial Intelligence in the Life Sciences, Volume 10 Author(s): Rajashekar Korutla, Tanisha Garg, Shridhar Sunilkumar Pol, Venkatesh Shivandi, Samuel Gnanam, Kumara Swamy Padari, Saeed Amal